Will take 4-5 months to publish Phase-3 trial data of ZyCoV-D: Zydus MD

The Ahmedabad-based pharma company has received approval from DCGI for ZyCOV-D, the world's first and India's indigenously developed DNA-based vaccine for Covid

Managing Director of Zydus Group Dr Sharvil Patel on Saturday said that his firm will soon apply for the Indian drug regulator's approval to conduct trials of ZyCoV-D on children above 2 years and added that it will take another 4-5 months to publish the phase 3 data of the Covid vaccine.

The Ahmedabad-based pharma company has received approval from the Drugs Controller General of India (DCGI) for ZyCOV-D, the world's first and India's indigenously developed DNA-based vaccine for COVID-19 which will be administered in humans including adults and children 12 years and above.

However, the pharma company has not published phase